logo
Managing Ulcerative Colitis: Why Lifestyle Remedies Aren't Always Enough

Managing Ulcerative Colitis: Why Lifestyle Remedies Aren't Always Enough

Health Line10-07-2025
Ulcerative colitis (UC) is a chronic disease that causes inflammation and sores in the lining of your colon. It's a complicated disease that can interfere with your quality of life.
Ulcerative colitis (UC) can significantly affect your quality of life. You may miss work or school and feel limited by the kinds of activities you can do because of urgent bowel activity. However, remission is possible with UC.
Lifestyle changes and certain supplements may make you feel better. Medications and a smart treatment plan may reduce your risk of serious complications and allow you to experience longer periods of remission in a way that lifestyle changes alone cannot.
Read on to learn more about the role of lifestyle changes in UC and the reasons for considering medical treatments in the long run.
Role of lifestyle changes and supplements
UC affects people differently, so you may see an improvement in your condition with lifestyle changes and supplements. These lifestyle changes aren't meant to replace a medication regimen. Talk with a doctor to see if adding these to your daily routine is safe and advisable.
Diet doesn't cause UC, but avoiding certain foods may lessen the severity of flare-ups and reduce symptoms. These include greasy foods and vegetables that cause gas, like cauliflower and broccoli. Avoiding high fiber foods, lactose, and caffeine may also improve your symptoms. A 2023 paper states that dietary changes can help reduce symptoms of UC.
Some people with UC notice positive changes resulting from light exercise, relaxation techniques, and breathing exercises. These activities may reduce stress levels and help you cope with flare-ups.
Some nutritional supplements may also be helpful. Studies have shown that taking fish oil and probiotics may have a role in helping people with UC. Fish oil may help reduce inflammation, and probiotics can add good bacteria to your intestinal tract.
While lifestyle changes and supplements may help ease symptoms, they aren't enough to manage UC alone. UC is a chronic condition that can lead to serious complications without proper medical treatment. The primary goal of care is achieving and maintaining remission, which typically requires prescribed therapies alongside supportive measures.
Here are some reasons why you can speak with your doctor or gastroenterologist about prescription medications and treatment.
Ulcerative colitis complications
Lifestyle changes and supplements may not control flare-ups as effectively as prescription medications. As a result, you may continue to have repeated bouts of diarrhea and bloody stool. The more attacks you have, the greater risk you have for complications and the more inflammation you'll experience. Research shows that inflammation plays a key role in the development of colorectal cancer in people with UC.
Sores or ulcers in the lining of your colon can bleed and lead to bloody stools, while long-term intestinal bleeding can cause iron deficiency anemia. Symptoms of this condition include dizziness, fatigue, and lightheadedness. Your doctor can recommend iron supplements to correct this deficiency, but it's also important to treat the underlying cause of bleeding. A prescription medication for UC can stop inflammation and heal ulcers in your colon.
Chronic diarrhea from UC can also cause problems. Diarrhea can decrease your fluid levels, causing dehydration and electrolyte imbalances. Signs of dehydration include:
excessive thirst
low urine output
headaches
dry skin
dizziness
confusion
Drinking more fluids can counter the effects of diarrhea. However, medication can treat the source of the inflammation to control symptoms and stop repeated relapses.
Drug therapies
There isn't a cure for UC, but remission can make it feel like the condition is no longer affecting your daily life. Several medications are available to help reduce flare-ups and keep symptoms at bay. Talk with your healthcare team about your options. With the right treatment, many people go months or even years with no symptoms.
Prescription medications and drug therapies to help manage UC include:
Aminosalicylates (5-ASAs): Used primarily for mild to moderate UC, these drugs reduce inflammation in the lining of the colon. Options include sulfasalazine (Azulfidine), mesalamine (Pentasa), olsalazine (Dipentum), and balsalazide (Colazal, Giazo). This class of drugs is also recommended for maintenance treatment to help prevent flare-ups.
Tofacitinib (Xeljanz): This is a newer option in a class of medications called Janus kinase (JAK) inhibitors. It works in a unique way to reduce inflammation in people with moderate to severe UC.
Corticosteroids: Prescribed for moderate to severe flare-ups, this class of drugs, including prednisone or budesonide, reduces inflammation by suppressing the immune system. Because of potential side effects, they're typically not intended for long-term or maintenance use.
Immunomodulators: These medications, also for moderate to severe symptoms, help suppress the immune response and are often used in conjunction with a corticosteroid. A few options include azathioprine (Azasan, Imuran), tacrolimus (Prograf), and 6-mercaptopurine.
Biologics: Used for moderate to severe UC that doesn't respond to other treatments, these injections or infusions block the proteins that cause inflammation in your colon. Examples include:
anti-TNF agents such as adalimumab (Humira), infliximab (Remicade), golimumab (Simponi)
integrin receptor antagonists such as vedolizumab (Entyvio)
IL-12/23 inhibitors such as ustekinumab (Stelara)
Targeted synthetic small molecules and JAK inhibitors: The first oral JAK inhibitor approved for UC in 2023 by the Food and Drug Administration (FDA), tofacitinib (Xeljanz) is used in moderate to severe cases, particularly when other biologics haven't worked. Newer JAK inhibitors like upadacitinib (Rinvoq) have also been approved more recently. These drugs fall under a broader class known as targeted synthetic small molecules, which also includes newer options like ozanimod (Zeposia) and etrasimod (Velsipity). These medications work by selectively modulating immune pathways involved in inflammation.
Newer biologics such as risankizumab-rzaa (Skyrizi), mirikizumab-mrkz (Omvoh), and guselkumab (Tremfya) are also emerging options for people whose UC hasn't responded to older therapies.
Surgery is another option, but only as a last resort in severe cases. Surgeons will remove the entire colon in the case of colon rupture or uncontrolled bleeding. High cancer risk is another reason surgery may be recommended.
Although the procedure can cure UC, it requires a permanent ileostomy, or creation of a J-pouch. An ileostomy is when the end of the small intestine is connected to an opening in the belly, called a stoma. Waste comes out through this opening into a special bag that sticks to the skin. It's a new way for the body to get rid of waste in the colon's absence.
Reduce the risk of colorectal cancer
Colorectal cancer is a significant complication of UC. The risk of developing this type of cancer depends on the severity of your symptoms and how long you've had the disease. However, remission may cut your risk of cancer.
Lifestyle changes and nutritional supplements aren't meant to replace any recommendations or prescriptions from your doctor. When taken as directed, medications reduce inflammation in your colon and help you achieve remission sooner. The longer your disease remains in remission, the less likely you are to develop colon cancer and precancerous cells.
Being under the supervision of a specialist also gives your gastroenterologist the opportunity to monitor your condition over time and schedule appropriate screenings. Once you're diagnosed with UC, you'll need to receive periodic colon cancer screenings — how often depends on your own health and family history.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AI in the Mental Health Market 2025-2029: Rise of Hyper-Personalization Drives Revenues at 30.9% CAGR
AI in the Mental Health Market 2025-2029: Rise of Hyper-Personalization Drives Revenues at 30.9% CAGR

Yahoo

time26 minutes ago

  • Yahoo

AI in the Mental Health Market 2025-2029: Rise of Hyper-Personalization Drives Revenues at 30.9% CAGR

Key market opportunities in the AI for mental health sector include addressing the mental healthcare gap and enhancing accessibility, leveraging advanced AI tech, and regulatory support Dublin, Aug. 18, 2025 (GLOBE NEWSWIRE) -- The "AI in Mental Health Market 2025-2029" has been added to offering. The AI in mental health market is poised for significant expansion, with projections indicating an increase of USD 3.13 billion from 2024 to 2029, advancing at a robust CAGR of 30.9% during this period. This comprehensive report provides an in-depth analysis of the market's size, future forecasts, trends, growth drivers, challenges, and a thorough vendor review encompassing approximately 25 vendors. The market's growth is largely fueled by the widening gap in mental healthcare accessibility, alongside rapid advancements in AI and machine learning technologies. Increased investments and evolving regulatory frameworks further bolster the market environment. Key drivers include the surge in hyper-personalization and precision mental healthcare, along with a strategic transition from direct-to-consumer to enterprise models. The incorporation of generative AI to enhance therapeutic interactions is set to amplify market demand. The report encompasses several critical areas such as market sizing, forecasts, and industry analyses. This report combines primary and secondary research, incorporating insights from key industry players, and delivers a sweeping view of market size, regional segmentation, vendor dynamics, and analyses of leading industry enterprises. Both historical and future data are meticulously documented. The AI in mental health market is segmented as follows: By Component Software Services By Technology Natural language processing Deep learning and machine learning Context-aware computing Others By End-user Hospitals and clinics Mental health centers Research institutions Others By Geographical Landscape North America Europe APAC Middle East and Africa South America A thorough vendor analysis aids clients in enhancing their market stance. Detailed examinations of prominent players such as Bark Technologies Inc., BigHealth, Cognoa Inc., Lyra Health Inc., and Spring Health Inc., among others, are provided. This analysis also outlines emerging trends and challenges set to impact market trajectory, equipping companies to capitalize on forthcoming growth opportunities. A selection of companies mentioned in this report includes, but is not limited to: Bark Technologies Inc. BigHealth BioBeats Group Ltd. Cognoa Inc. Infinit Care Inc. Kintsugi Mindful Wellness Inc. Lyra Health Inc. meQuilibrium Inc. Meru Health Inc. Mirror Mental Health LLC. NextGen Healthcare Inc. Quartet Health Inc. SilverCloud Health Ltd. Spring Health Inc. Syra Health Corp. TALKSPACE INC. Woebot Labs Inc. Wysa Inc. Xunfei Healthcare Technology Co. Ltd. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

New Bedford mosquito sample tests positive for West Nile virus again. What to know.
New Bedford mosquito sample tests positive for West Nile virus again. What to know.

Yahoo

timean hour ago

  • Yahoo

New Bedford mosquito sample tests positive for West Nile virus again. What to know.

West Nile virus has been detected in a mosquito sample in New Bedford for the second time in recent weeks. The Massachusetts Department of Public Health notified local health officials about the finding, which was in a primarily bird-biting mosquito near Oak Grove Cemetery on Parker Street, according to a community announcement. The risk level for West Nile virus in New Bedford, Fairhaven and Acushnet is moderate. Preventative measures include wearing mosquito repellent between dusk and dawn, wearing long sleeves and pants during those hours, using mosquito netting on baby carriages and playpens, and emptying standing water around homes twice weekly. The Bristol County Mosquito Project conducted targeted ground-spraying Aug. 14 in the Oak Grove Cemetery area. This spraying supplements the county's normal weekly ground-spraying, which occurs seasonally from early June through September and targets parks and other locations that host large public events. Weekly sprayings take place every Thursday during the summer between 2 a.m. and sunrise in locations around Buttonwood Park, Brooklawn Park, Fort Taber, Hazelwood Park, Riverside Park, Clasky Common Park, Ashley Park, Wing's Court, Custom House Square and other parts of downtown. Residents near targeted areas may want to close their windows in the evenings before spraying. In the event of inclement weather, spraying will be moved to early Friday morning. The annual monitoring program involves crews placing traps and collecting specimens to monitor the mosquito population throughout the summer. It also helps track whether any mosquitoes are carrying Eastern equine encephalitis or West Nile virus. West Nile virus is a mosquito-borne virus that can cause illness ranging from a mild fever to more serious disease. It is most commonly spread to people through the bite of an infected mosquito. Positive mosquito samples for West Nile are not uncommon in the summer months and have been found in cities and towns across the state in recent weeks. The New Bedford Health Department recommends several precautionary measures to help protect against mosquito bites: Be aware of peak mosquito hours: Mosquitoes are most active from dusk to dawn. Consider rescheduling outdoor activities during these times or take extra precautions with repellent and protective clothing, especially if you spend a lot of time outdoors. Clothing can help reduce mosquito bites: Wearing long sleeves, long pants and socks when outdoors can help keep mosquitoes away from your skin, even though it may be challenging in hot weather. Apply insect repellent when outdoors: Use a repellent with DEET, permethrin, picaridin, IR3535 or oil of lemon eucalyptus according to the product label instructions. DEET products should not be used on infants under 2 months of age and should be used in concentrations of 30% or less on older children. Oil of lemon eucalyptus should not be used on children under 3 years of age. Permethrin products are intended for use on items such as clothing, shoes, bed nets and camping gear and should not be applied to skin. Drain standing water: Mosquitoes lay eggs in standing water. Limit breeding sites around your home by draining or removing items that hold water. Check rain gutters and drains, empty unused flowerpots and wading pools, and change water in birdbaths frequently. Install or repair screens: Some mosquitoes can enter homes. Keep them outside by ensuring tight-fitting screens on all windows and doors. For more information and the state's risk-level map, visit This story was created by reporter Beth McDermott, bmcdermott1@ with the assistance of Artificial Intelligence (AI). Journalists were involved in every step of the information gathering, review, editing and publishing process. Learn more at This article originally appeared on Standard-Times: West Nile virus detected in mosquito sample in New Bedford Solve the daily Crossword

AI Is the New Dr Google — Across the Globe
AI Is the New Dr Google — Across the Globe

Medscape

timean hour ago

  • Medscape

AI Is the New Dr Google — Across the Globe

Patients arriving at appointments with researched information is not new, but artificial intelligence (AI) tools such as ChatGPT are changing the dynamics. Their confident presentation can leave physicians feeling that their expertise is challenged. Kumara Raja Sundar, MD, a family medicine physician at Kaiser Permanente Burien Medical Center in Burien, Washington, highlighted this trend in a recent article published in JAMA . A patient visited Sundar's clinic reporting dizziness and described her symptoms with unusual precision: 'It's not vertigo, but more like a presyncope feeling.' She then suggested that the tilt table test might be useful for diagnosis. Occasionally, patient questions reveal subtle familiarity with medical jargon. This may indicate that they either have relevant training or have studied the subject extensively. Curious, Sundar asked if she worked in the healthcare sector. She replied that she had consulted ChatGPT, which recommended the tilt table test. For years, patients have brought newspaper clippings, internet research, and advice from friends and relatives to consultations. Suggestions shared in WhatsApp groups have become a regular part of clinical discussions. Sundar noted that this particular encounter was different. The patient's tone and level of detail conveyed competence, and the confidence with which she presented the information subtly challenged his clinical judgment and treatment plans. Clinical Practice It is not surprising that large language models (LLMs), such as ChatGPT, are appealing. Recent studies have confirmed their remarkable strengths in logical reasoning and interpersonal communication. However, a direct comparison between LLMs and physicians is unfair. Clinicians often face immense pressure, including constrained consultation times, overflowing inboxes, and a healthcare system that demands productivity and efficiency. Even skilled professionals struggle to perform optimally under adverse conditions. In contrast, generative AI is functionally limitless. This imbalance creates an unrealistic benchmark; however, this is today's reality. Patients want clear answers; more importantly, they want to feel heard, understood, and reassured. Patients value accurate information but also want to feel recognized, reassured, and heard. 'Unfortunately, under the weight of competing demands, which is what often slips for me not just because of systemic constraints but also because I am merely human,' Sundar wrote. Despite the capabilities of generative AI, patients still visit doctors. Though these tools deliver confidently worded suggestions, they inevitably conclude: 'Consult a healthcare professional.' The ultimate responsibility for liability, diagnostics, prescriptions, and sick notes remains with physicians. Patient Interaction In practice, this means dealing with requests, such as a tilt table test for intermittent vertigo, a procedure that is not uncommon but often inappropriate. 'I find myself explaining concepts such as overdiagnosis, false positives, or other risks of unnecessary testing. At best, the patient understands the ideas, which may not resonate when one is experiencing symptoms. At worst, I sound dismissive. There is no function that tells ChatGPT that clinicians lack routine access to tilt-table testing or that echocardiogram appointments are delayed because of staff shortages. I have to carry those constraints into the examination room while still trying to preserve trust,' Sundar emphasized in his article. When I speak with medical students, I notice a different kind of paternalism creeping in. And I have caught it in my inner monologue, even if I do not say it aloud. The old line, 'They probably WebMD'd it and think they have cancer,' has morphed into the newer, just-as-dismissive line, 'They probably ChatGPT'd it and are going to tell us what to order.' It often reflects defensiveness from clinicians rather than genuine engagement and carries an implicit message: We still know the best. 'It is an attitude that risks eroding sacred and fragile trust between clinicians and patients. It reinforces the feeling that we are not 'in it' with our patients and are truly gatekeeping rather than partnering. Ironically, that is often why I hear patients turn to LLMs in the first place,' Sundar concluded . Patient Advocacy One patient said plainly, 'This is how I can advocate for myself better.' The word 'advocate' struck Sundar, capturing the effort required to persuade someone with more authority. Although clinicians still control access to tests, referrals, and treatment plans, the term conveys a sense of preparing for a fight. When patients feel unheard, gathering knowledge becomes a strategy to be taken seriously. In such situations, the usual approach of explaining false-positive test results, overdiagnosis, and test characteristics is often ineffective. From the patient's perspective, this sounds more like, 'I still know more than you, no matter what tool you used, and I'm going to overwhelm you with things you don't understand.' Physician Role The role of physicians is constantly evolving. The transition from physician-as-authority to physician-as-advisor is intensifying. Patients increasingly present with expectations shaped by nonevidence-based sources, often misaligned with the clinical reality. As Sundar observed, 'They arm themselves with knowledge to be heard.' This necessitates a professional duty to respond with understanding rather than resistance. His approach centers on emotional acknowledgment before clinical discussion: 'I say, 'We'll discuss diagnostic options together. But first, I want to express my condolences. I can hardly imagine how you feel. I want to tackle this with you and develop a plan.'' He emphasized, 'This acknowledgment was the real door opener.' Global Trend What began as a US trend observed by Sundar has now spread worldwide, with patients increasingly arriving at consultations armed with medical knowledge from tools like ChatGPT rather than just 'Dr Google.' Clinicians across health systems have reported that digitally informed patients now comprise the majority. In a forum discussion, physicians from various disciplines shared their experiences, highlighting how previously informed patients are now the norm. Inquiries often focus on specific laboratory values, particularly vitamin D or hormone tests. In gynecologic consultations, Internet research on menstrual disorders has become a routine part of patient interactions, with an overwhelming range of answers available online. ' Chanice ,' a Coliquio user who's a gynecologist, shared, 'The answers range from, 'It's normal; it can happen' to 'You won't live long.'' 'It's also common to Google medication side effects, and usually, women end up experiencing pretty much every side effect, even though they didn't have them before.' How should doctors respond to this trend? Opinions are clear: openness, education, and transparency are essential and ideally delivered in a structured manner. 'Get the patients on board; educate them. In writing! Each and every one of them. Once it's put into words, it's no longer a job. Invest time in educating patients to correct misleading promises made by health insurance companies and politicians,' commented another user, Jörg Christian Nast, a specialist in gynecology and obstetrics. The presence of digitally informed patients is increasingly seen not only as a challenge but also as an opportunity. Conversations with these patients can be constructive, but they can also generate unrealistic demands or heated debates. Thus, a professional, calm, and explanatory approach remains crucial, and at times, a dose of humor can help. Another user who specializes in internal medicine added, 'The term 'online consultation' takes on a whole new meaning.' The full forum discussion, 'The Most Frequently Asked 'Dr. Google' Questions,' can be found here. Find out what young physicians think about AI and the evolving doctor-patient relationship in our interview with Christian Becker, MD, MHBA, University Medical Center Göttingen, Göttingen, Germany, and a spokesperson for the Young German Society for Internal Medicine. Read the full interview here.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store